Detalhe da pesquisa
1.
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Breast Cancer Res Treat
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743174
2.
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Breast Cancer Res Treat
; 192(3): 563-571, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35119530
3.
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Breast Cancer Res Treat
; 195(3): 333-340, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976513
4.
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Eur Radiol
; 32(9): 6514-6525, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384456
5.
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
Br J Cancer
; 125(2): 299-304, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017085
6.
Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience.
Breast Cancer Res Treat
; 188(2): 535-545, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683521
7.
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Breast Cancer Res Treat
; 180(3): 809-817, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170635
8.
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience.
Breast Cancer Res Treat
; 179(1): 101-111, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31535318
9.
Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Breast Cancer Res Treat
; 168(1): 249-258, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128896
10.
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.
Breast J
; 24(3): 253-259, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28833867
11.
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.
Cancer Imaging
; 23(1): 53, 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254225
12.
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
Clin Breast Cancer
; 22(7): e825-e831, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840514
13.
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.
Breast Cancer Res Treat
; 119(2): 315-23, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19247830
14.
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience.
Cancer Treat Res Commun
; 24: 100188, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619830
15.
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Clin Cancer Res
; 26(3): 608-622, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591187
16.
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res Treat
; 116(1): 53-68, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18592370
17.
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial.
J Clin Oncol
; : JCO2017748392, 2018 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235087
18.
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.
Cold Spring Harb Mol Case Stud
; 4(2)2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29610388
19.
Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Breast
; 36: 54-59, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968585
20.
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer.
Target Oncol
; 11(5): 579-591, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27181019